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Abstract

Purpose: Interleukin-1 beta (IL-1β) is a cytokine that participates in the regulation of immune responses and
inflammatory reactions. It is hypothesized that IL-1 levels may be elevated in patients suffering from
temporomandibular joint dysfunction. The purpose of this study was to determine the association of IL-1β
expression with TMD using an immunohistochemical approach to evaluate the joint disc.
Materials and methods: A total of 39 human temporomandibular joint disc samples were collected, with 31
samples in the test group. Nineteen of the test group samples were from discs of patients with anterior disc
displacement with reduction, and 12 of the samples were from patients with anterior disc displacement without
reduction. Eight control samples were used in the control group. The samples were immunostained and
evaluated on both quantity and intensity of staining.
Results: There was a statistically significant difference (p < 0.05) between the control and test groups for both
quantity and intensity of staining.
Conclusion: IL-1β plays a role in the inflammatory process and degradation of TMJ discs in patients with TMJ
dysfunctions.
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Introduction

The temporomandibular joint has the capability to adapt and remodel according to its functional
demands. The fibrocartilaginous disc in the TMJ consists of regularly arranged collagen fibers and
fibroblast-like cells. Few and scattered, chondrocyte-like cells and fibrochondrocytes can also be
appreciated. The disc is responsible for distributing the pressure loads of the TMJ during masticatory
function.1 When the disc is overloaded, an inflammatory process begins, and the disc undergoes
remodeling. If the overloading persists for an extended period of time, the disc may undergo structural
changes to adapt to the excessive forces.2 The structural changes often result in abnormal positional
relationships of the articular disc to the mandibular condyle and articular eminence.
These abnormal positional relationships are categorized into a group of temporomandibular joint
disorders called internal derangements (ID).3 There are two common types of ID: anterior disc
displacement with reduction (ADDwR) and anterior disc displacement without reduction (ADDwoR).
Depending on the stage of derangement, the disc either reseats itself on top of the mandibular condyle
when the mouth is opened (ADDwR), or the disc remains in a malposition in relation to the condyle
throughout all joint movements (ADDwoR).4

These mechanical joint disturbances cause the joint to undergo structural changes in order to adapt to
IDs. Acute macrotrauma is the major cause of disc structural changes. The structural changes are
mostly a result of chemical mediators being released in the joint space as well as in the disc itself.5 The
inflammatory process is a coordinated response against trauma. However, when the initiating
inflammatory agent is not removed, the disc’s response leads to pathological changes. Interleukin-1
plays an initial and vital role in this inflammatory process and ultimately the cartilage degradation of
TMJ discs.6
In normal, healthy TMJ discs, there are virtually no pro-inflammatory cytokines present.7 Soon after
TMJ discs are subjected to excessive loads and function, they begin to undergo pathologic changes.
These mechanical disturbances produce an imbalance between anabolic and catabolic processes,
which progressively alters TMJ disc tissue.8 Healthy disc tissue is undergoing a constant process of
remodeling, whereby collagen and proteoglycan synthesis is balanced by enzymatic extracellular
matrix (ECM) degradation.9 Damage of the TMJ disc is associated with excessive catabolic activity that
results from cytokines and proteases.10 This causes the ECM to remodel.11 Rates of ECM degradation
increase, while ECM synthesis decreases.12 A number of pro-inflammatory cytokines have been
implicated in the regulation of ECM remodeling.13 Interleukin-1 beta (IL-1β) has been shown to be
increased in joint degeneration and has been shown to be present in joint synovial fluid, but its
presence has not been demonstrated in human TMJ tissue.14,15 Interleukin-1 beta is one of the most
prevalent and first cytokines produced as a response to the excessive loads placed on the TMJ.16 The
release of IL-1 initiates a cascade of events that ultimately leads to tissue alteration. This cascade alters
the ECM by depleting matrix substances such as collagen and proteoglycans.
Although the role of IL-1β in inflammation and joint dysfunction is well known, previous studies have
only investigated the presence of IL-1β in animal models, cadavers, or synovial fluid of
humans.6,7,16 Based on previous studies, the goal of this study was to histochemically evaluate the
expression of IL-1β receptor in the discs from live patients who were diagnosed with TMD. To the
authors’ knowledge, this is the first study that has used an immunohistochemical approach to
characterize the expression of IL-1β in human TMJ disc tissue.

Materials and Methods
Patients and samples

A total of 36 disc samples were obtained for this study. The discs were collected from patients treated
between 2002 and 2009 at the Hospital Universitario Evangelico de Curitiba. Eight virtually unaffected
human discs were included in the control group for the study.
The subjects did not have any of the following: use of orthodontic appliances; chronic usage of antiinflammatory drugs; history of diabetes, hepatitis, or HIV infection; immunosuppressive chemotherapy
history of any disease known to severely compromise immune function; current pregnancy or
lactation; dentofacial deformity; major jaw trauma previously, TMJ surgery; or previous steroid
injection in the TMJ. The subjects completed personal medical history questionnaires and, within a
protocol approved by an Institutional Review Board, signed a consent form after being advised of the
nature of the study. All patients were asked to complete a pain questionnaire, and an experienced oral
and maxillofacial surgeon performed a clinical examination. The clinical examination included palpation

of the TMJ region, noting the occurrence of painful opening/closing of the mouth, and listening for
crepitation.
The patients considered to be affected were treated surgically when they presented painful clinical
signs of disc displacement after unsuccessful non-surgical treatment for at least six months. Patients
presenting with pain related to muscular spasms were not included in this study. For the
complementary exams, all patients received a panoramic radiograph and MRI imaging studies.
The subjects were included in clinical categories, according to the presence or absence of disc
displacement.
The test group included a total of 31 samples of discs that were diagnosed with TMJ dysfunctions. This
group was separated into anterior disc displacement with reduction (n = 19) and ADDwoR (n = 12). The
control group included a total of eight samples. The discs of these patients were removed for reasons
other than TMJ dysfunction. Four of the patients presented with condyle fractures that were
confirmed by radiographs and CT scans. Four other control samples were obtained from patients who
displayed active condyle hyperplasia. Wedges of the control discs were removed from the posterior
regions so that the disc was able to physiologically adapt to the head of the condyle during function.

Interleukin-1β immunohistochemical analysis

The TMJ discs were deparaffinized with 100% xylene (3 min) and a 50:50 mix of xylene and ethanol
(3 min). The discs were then rehydrated with absolute ethanol (2 × 3 min), 90% ethanol (3 min), 70%
ethanol (3 min), and distilled water (3 min).
The discs were cold incubated for 24 h with monoclonal IL-1β receptor antibodies (Thermo Fisher
Scientific, Rockford, IL, USA) diluted 1:2 000 in a solution of 0.1 M NaPO4 buffer, 0.3% Triton, and
0.25% carrageenan. Biotinylated secondary anti-goat/anti-rabbit was diluted 1:100 in the same
solution as the primary antibodies and then added to the discs for two hours. Avidin-biotin-peroxidase
complex was then added to the slides and allowed to incubate for two hours. The immunoreactions
were visualized by incubating the slides with 3.3′ diaminobenzidine chromogen. The slides were once
again dehydrated and mounted.

Evaluation of immunohistochemistry

Interleukin-1β receptor staining was identified as either positive or negative for each disc. Positive
staining was defined as the presence of brown chromogen detection, distributed within the cytoplasm
or in the immediate lacunar/pericellular space. Two blinded observers evaluated the percentage of
immunopositive cells. The observers scored the percentages based on a predetermined scale (0 = < 5%;
1 = 6–30%; 2 = 31–50%, 3 = 51–75%; 4 = 76–100%). Counting was performed at 200× magnification.
The intensity of the staining was also categorized on a four-point predetermined scale (0 = no
detectable staining, 1 = light staining, 2 = moderate staining, 3 = strong staining, and 4 = very strong
staining). If the observers’ grading disagreed by more than one point, the field of view that was being
graded was thrown out and a new field of view was chosen. For each disc, five areas were analyzed for
both percentage and intensity of staining.

Statistical analysis

SPSS version 22.0 (SPSS Institute, Inc., Chicago, IL, USA) was used for the statistical analyses. To analyze
the area and density, the average of the results from all available samples of each patient was
considered. Means were compared using one-way ANOVA and least significant difference test for
multiple comparisons of groups. A value of p < 0.05 indicated a statistical difference.

Results

Immunoreactivity for IL-1β expression was confirmed, following IHC. Staining was localized to cells
expressing IL-1β receptors. All experimental samples were identified as positively stained. The samples
were first analyzed for the percentage of positively stained cells. The experimental groups, ADDwR
(Figure 1) and ADDwoR (Figure 2), were both statistically significant when compared to the control
group (Figure 3). As shown in Table 1 below, IL-1β receptor expression was statistically significant for
both ADDwR and ADDwoR (p < 0.001). However, there was no significant difference of percentage of
positively stained cells between each of the experimental groups (p = 0.063) (Table 1).
Figure 1 Anterior disc displacement with reduction.

Figure 2 Anterior disc displacement without reduction.

Figure 3 Control.

Table 1 Immunoreaction IL-1β
Group

# of positively stained
fibroblasts
n

p value*

Mean Median Minimum Maximum Standard
deviation
Control
8
0.450 0.500
0.000
1.000
0.366
With red
19
2.147 2.400
0.200
4.000
0.882
Without red 12
2.733 2.800
1.200
4.000
0.939
Control × with red: p<0.001; Control × without red: p < 0.001; With red × without red: p = 0.063.
* One-way ANOVA and least significant difference test for multiple comparisons; p<0.05.

<0.001

The intensity of staining for each sample was also analyzed. ADDwR staining intensity was statistically
significant compared to the control tissue (p < 0.001). Additionally, ADDwoR staining intensity was also
statistically significant compared to the control samples (p < 0.001). There was no statistical difference
between the two experimental groups (p = 0.170). The results are displayed below in Table 2.
Table 2 Intensity of fibroblast staining
Group

Intensity of
fibroblast staining
n

p value*
Mean Median Minimum Maximum Standard
deviation
0.700 0.600
0.000
1.600
0.545
2.074 2.200
0.200
3.400
0.854
2.483 2.600
1.200
4.000
0.824

Control
8
With red
19
Without red
12
Notes:
Control × with red: p < 0.001; Control × without red: p < 0.001; With red × without red: p = 0.170.
* One-way ANOVA and least significant difference test for multiple comparisons; p < 0.05.

Discussion

<0.001

In the healthy TMJ disc, the rate of synthesis and breakdown of the discal tissue is in equilibrium due to
the intricate, but delicate regulation by growth factors and cytokines. Disc cells are likely to play a
substantial role in the turnover of the disc matrix. In the diseased state, disc degeneration is associated
with a change in the balance between anti- and pro-inflammatory mediators.17

Interleukin-1β has been shown to play an important role in the pathophysiology of joint diseases.18 It
has been shown to be present in high concentrations in both the acute and chronic stages of
inflammation.19 Previous disc displacement studies have focused on the synovial fluid and the synovial
lining cells.7,16,20 These previous studies have found increased expression of many inflammatory
mediators, including interleukins, matrix metalloproteases (MMPs), tumor necrosis factor (TNF),
interferon gamma, and transforming growth factor beta (TGF beta). Therefore, the aim of this study
was to investigate the expression of IL-1β released from fibroblasts within disc tissue.
The results of this study were similar to the results shown by studies that investigated the expression
of IL-1β in synovial fluid.5 There was a statistically significant difference between the control group and
the ADDwR and between the control group and ADDwoR. This suggests that excessive forces on the
articular disc initiate similar inflammatory cascades as seen in synovial fluid.
Increased IL-1 beta expression has been shown to not only increase inflammation, but also increase the
production and release of other mediators that are responsible for tissue changes and degradation.
Multiple studies injected IL-1β into the joint capsules of TMJs in animal models or in tissue samples
from humans. They used various laboratory methods to quantify the amounts of secondary mediators
released into the TMJ after hours, days, and weeks. Nearly all of the studies correlated an increased
release of their test mediator following injection of IL-1 into the joint space. For example, a study
found that there was an increased expression of COX-2, IL-6, and MMP-9 following injection of IL-1 into
mouse TMJs. They followed the mice and found that the injections led to pathologic development,
dysfunction, and related pain in the joints.21 Additional studies have used similar methods, and they
found increased expression of ADAMTS, lumican, fibromodulin, hyaluronan synthase 3, proteoglycan-4,
COX 1 and 2, TNF alpha, IFN gamma, and many MMPs.8, 10, 11, 14, 22–27
With these findings in mind, treatment may be targeted at these pathologic mediators in addition to
the traditional therapy for disc dysfunction. Pharmacological treatment may be directed at molecules
that are responsible for disc degradation or it may be targeted at the mediators responsible for
initiating the inflammatory cascade. The findings in this study suggest that IL-1β is one of the initial and
most prevalent mediators found, not only in the synovial fluid, but also in the articular discs of the TMJ.
Specific pharmacological treatment targeted at IL-1β may be a beneficial treatment option to arrest
and prevent further disc degeneration.

Conclusion

Future analysis of IL-1β and its relationship with previously mentioned downstream mediators within
articular discs may contribute to a better understanding of TMJ dysfunction. The findings may also help
direct treatment to specific mediators that are responsible for disc remodeling and destruction.
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